Skip to content
OpenCapital
Get started

Viatris VTRS Emerging Markets Segment — Cost of Sales

Similar metrics at other companies

NAG
NAGEPharmaceuticals segment — Cost of Sales
$0—
Oxford Industries logo
OXMEmerging Brands — Cost of goods sold
$17.92M+28.6%
Columbia Sportswear Company logo
COLMEMEA — Cost of Sales
$70.5M+33.4%
Indivior Pharmaceuticals, Inc. logo
INDVReportable Segment — Cost of Sales
$40M-9.1%
Baxter International logo
BAXPharmaceuticals — Cost of Sales
$458M+15.7%
Johnson Controls International logo
JCIEMEA — Cost of Sales
$829M+2.7%

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$18.49B+81.7%
Enterprise value$31.3B+29.5%
P/S1.3×+0.5×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%—
Net margin-2%-1.0pp
FCF margin12.3%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity1×+0.1×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept vtrs:CostOfProductAndServiceSoldAdjusted.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's emerging markets segment — cost of sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's emerging markets segment — cost of sales?
Viatris (VTRS) reported emerging markets segment — cost of sales of $219.6M in Q1 2026.
How has Viatris's emerging markets segment — cost of sales changed year-over-year?
Viatris's emerging markets segment — cost of sales increased by 3.2% year-over-year, from $212.8M to $219.6M.
What does emerging markets segment — cost of sales mean?
This metric includes the direct costs associated with manufacturing, sourcing, and distributing pharmaceutical products sold within the emerging markets segment. It encompasses raw materials, labor, and logistics costs specific to these regions. Monitoring this helps evaluate the segment's gross margin efficiency and the impact of regional supply chain costs.